• Increasingly, pregnant patients with inflammatory or autoimmune diseases use monoclonal
antibody biologics before conception, during pregnancy and while breastfeeding.• A minority …

Dietary changes can alter the human microbiome with potential detrimental consequences
for health. Given that environment, health, and evolution are interconnected, we ask: Could …

Objective Systemic lupus erythematosus (SLE) is a life-threatening disorder that affects
women at reproductive age. We evaluate the clinical impact of pregnancy in a cohort of …

Pregnancy in systemic lupus erythematosus (SLE) patients is associated with an increased
risk of adverse outcomes. During pregnancy, SLE patients have a higher rate of miscarriage …

Background Effectively predicting the risk of adverse pregnancy outcome (APO) in women
with systemic lupus erythematosus (SLE) during early and mid-pregnancy is a challenge …

Objective: Pregnancies of women with systemic lupus erythematosus (SLE) are associated
with preterm delivery. As preterm delivery is associated with long-term neurological …

Introduction Maternal glucocorticoid exposure increases the risk of preterm delivery;
however, the association between glucocorticoids and preterm premature rupture of …

Background Systemic lupus erythematosus (SLE) increases the incidence of adverse
pregnancy outcomes (APOs). Nevertheless, most of the data on SLE pregnancies were …

Remission or low disease activity at pregnancy onset are linked to improved foetal
outcomes in women with systemic lupus erythem Page 1 Clinical and Experimental …

Purpose To evaluate the association between disease activity, serological activity, and
adverse pregnancy outcomes (APOs) in women with systemic lupus erythematosus (SLE) …